The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

A Federal Trade Commission report claims that the amount of data social media companies collect on users amounts to 'vast ...

The agency said it filed a complaint in its administrative court alleging that CVS’s Caremark, Cigna’s Express Scripts and ...

Regulator claims companies rigged pharmaceutical supply chain competition in their favor, forced patients to pay more for ...

Last month, the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) jointly hosted a public meeting of the interagency “Strike ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The Federal Trade Commission has sued America’s largest prescription-drug “gatekeepers” over a “perverse drug ...

A recent email was a rather nondescript message from a person I do not know using a Gmail address; my name was the subject.

On September 4, 2024, the California Privacy Protection Agency ("CPPA") announced that it issued an Enforcement Advisory ...